Biotech Firm AN2 Therapeutics Prices US$69 Million IPO

Biopharmaceutical company AN2 Therapeutics, Inc. (Nasdaq: ANTX) began trading on the Nasdaq Global Select Market today. The firm’s initial public offering is looking to raise US$69.0 million and is expected to close on March 29, 2022.

The offering consists of 4.6 million common shares, upsized from 4.0 million shares, selling at US$15.00 per share. The company intends to use the proceeds to fund the clinical development and expansion of its drug candidate epetraborole, and for general corporate purposes, including working capital and operating expenses.

Cowen, SVB Leerink, and Evercore ISI act as the joint bookrunners for the said offering. The underwriters were granted a 30-day over-allotment option to purchase additional 690,000 shares at the same IPO price.

The Menlo Park-based biotech company is focused on developing epetraborole, an experimental oral treatment for patients with chronic non-tuberculous mycobacterial lung disease.

LOGO

Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Goliath Resources Hits 10.60 g/t Gold Over 22.82 Metres, Highest Grade Results In Third Distinct Rock Package At Surebet Discovery

Four Countries Control the Fertilizer That Feeds the World | Sage Potash

$10,000 Gold Is Just A Question of Time | Florian Grummes

Recommended

ESGold Outlines $24.3 Million NPV For Tailings Reprocessing Project

First Majestic Encounters 711 g/t Silver Equivalent Over 8.0 Metres In Ongoing Exploration At Los Gatos

Related News

LegalZoom Eyes Raising US$535.4 Million On Its Nasdaq IPO

Online legal platform LegalZoom.com Inc. announced Tuesday the pricing of its scheduled initial public offering...

Wednesday, June 30, 2021, 10:14:00 AM

Small-Cap IPOs That Are Pump-And-Dumps Are On The Rise, Thanks To Chinese Firms

The Financial Industry Regulatory Authority Inc. (FINRA) cautions that initial public offerings (IPOs) by international...

Saturday, November 19, 2022, 11:11:00 AM

Fitness Operator F45 Training Closes US$279 Million IPO

Fitness center franchisor F45 Training Holdings Inc. (NYSE: FXLV) closed its initial public offering Monday,...

Tuesday, July 20, 2021, 10:25:00 AM

Biotech Firm PepGen Prices US$108 Million IPO

Biopharmaceutical company PepGen, Inc. (Nasdaq: PEPG) began trading on the Nasdaq Global Select Market on...

Monday, May 9, 2022, 02:27:00 PM

Fintech SPAC AIB Acquisition Seeks To Raise US$75 Million In IPO

Special purpose acquisition company AIB Acquisition Corporation (Nasdaq: AIBBU) went public on the Nasdaq Global...

Wednesday, January 19, 2022, 02:16:00 PM